Treatment options for ocular adnexal lymphoma (OAL)

27Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Most lymphomas that involve the ocular adnexal structure are low grade, B cell, non-Hodgkin's lymphomas. The treatment depends upon the grade and stage of the disease. High grade lymhoma requires treatment with systemic chemotherapy whereas the localized low grade (extranodal marginal zone lymphoma) can be successfully managed with local radiotherapy. Chlamydia psittaci infection is associated with low grade ocular lymphoma; however there is wide geographic variation in the strength of this association. Blanket antibiotic therapy is not advised unless there is proof of an infective agent. The monoclonal antibody, rituximab, may be successful for CD20 positive lymphoma, although it is likely that rituximab will have better long-term results when used in combination with systemic chemotherapy. © 2009 Cohen, publisher and licensee Dove Medical Press Ltd.

Cite

CITATION STYLE

APA

Cohen, V. M. L. (2009). Treatment options for ocular adnexal lymphoma (OAL). Clinical Ophthalmology. Dove Medical Press Ltd. https://doi.org/10.2147/opth.s5828

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free